Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in Malaysia

Malaysian Journal of Medical Sciences

Volumn 20, Issue 2, 2013, Pages 53-62

  Daher, Aqil Mohammad ^a   Ismail, Nafeeza Mohd ^a   Agarwal, Renu ^a  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Adverse drug reaction reporting systems; Attitudes; Knowledge; Pharmacovigilance; Practice

Indexed keywords

ADVERSE OUTCOME; ARTICLE; ATTITUDE TO ILLNESS; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MALAYSIA; MALE; PHYSICIAN ATTITUDE; PRIVATE PRACTICE; PROFESSIONAL KNOWLEDGE; RISK FACTOR;

EID: 84874610174     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br J Clin Pharmacol. 1996;42(4):423-429.
2. Ibáñez Ruiz C, Frías Iniesta J. Adverse drug reactions and a program of voluntary notification: an opinion survey of primary care physicians. Aten Primaria. 1997;19(6):307-312.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205.
4. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA. 1997;277(4): 307-311.
5. Newsletter: MADRAC Bulletin [Internet]. 2012. Malaysia: National Pharmaceutical Control Bureau; cited [2012 Apr].p.12 Available from http://www. bpfk.gov.my.
6. Zoriah A, Tan CS, Nurul SB. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2006;16(2):223-228.
7. Quek DKL. Healthcare cost and challenges for Malaysia. MMA news. 2010;40(3):4-8.
8. Belton KJ. The European Pharmacovigilance Research Group. Attitude survey of adverse drugreaction reporting by healthcare professionals across the European Union. Eur J Clin Pharmacol. 1997;52(6):423-427.
9. Aqil MD, Farnaza A. Assessing the perceptions of a biostatistics and epidemiology module: viwews of year 2 medical students from a Malaysian University. A cross sectional survey. BMC Med Edu. 2010;10:34. doi: 10.1186/1472-6920-10-34
10. Van Grootheest AC, van Puijenbroek EP, de Jongvan den Berg LT. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(3):205-210.
11. Morrison-Griffiths S, Walley TJ, Park BK Breckenridge AM, Pirmohamed M. Reporting of adverse drug reactions by nurses. Lancet. 2003;361(9366):1347-1348.
12. Blenkinsopp A, Wilkie P, Wang M. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148-156.
13. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting Part I. Adverse Drug React Acute Poisoning Rev. 1985;4(4):213-230.
14. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting - Part II. Adverse Drug React Acute Poisoning Rev. 1986;5(1):23-55.
15. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting - Part III. Adverse Drug React Acute Poisoning Rev. 1989;8(4):203-215.
16. Chatterjee S, Lyle N, Ghosh S. A Survey of the Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting by Clinicians in Eastern India. Drug Saf. 2006;29(7):641-642.
17. Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers. Nat Med J India. 2002;15(1):24-26.
18. Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chinese Med J. 2004;116(6):856-861.
19. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Cin Pharmacol. 1995;39(3):223-226.
20. Pouget-Zago P, Lapeyre-Mestre M, Bagheri H, Montastruc JL. Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées. Therapie. 1995;50(5):459-462.
21. McGettigan P, Golden J, Conroy RM, Arthur N, Feely J. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997;44(1):98-100.
22. Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825-833.
23. Rouleau B, Lavoie L, Leblanc J, Moretti S, Collin C. Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec. Drug Information J. 2011;45:627-639.
24. Rogers AS, Isreal E, Smith CR, Levine D, McBean AM, Valente C, et al. Physician knowledge, attitudes, and behaviour related to reporting adverse drug events. Arch Intern Med. 1988;148(7):1596-1600.
25. Enwere OO, Fawole OI. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf. 2008;17(5):517-522.
26. Elkalmia R M, Hassalia MA, Izham MM, Liaua SY, Awaisu A. A qualitative study exploring barriers and facilitators for reporting of adverse drug reactions (ADRs) among community pharmacists in Malaysia. J Pharmaceutical Health Services Res. 2011;2(2): 71-78. doi: 10.1111/j.1759-8893.2011.00037.x
27. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.
28. Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández-Díaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073-1082.
29. Eland A, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmcol. 1999;48(4):623-627.
30. Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol. 1992;34(5):421-426.
31. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of Under-Reporting of adverse Drug Reactions: A Systematic Review. Drug Saf. 2009;32(1):19-31. doi: 10.2165/00002018-- 200932010-00002.
32. Inman WHW. Assessment of drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Honolulu (ON): McMaster University Library Press; 1976. p. 17-24.
33. Inman WHW, Weber JCT. The United Kingdom. In: Inman WHW, editor. Monitoring for drug safety. 2nd ed. Lancaster: MTP Press Ltd; 1986. p. 13-47.
34. Inman WHW. Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol. 1996;41(5): 434-435.